Radiotherapy for the palliation of prostate cancer

Seminars in Surgical Oncology

Volumn 18, Issue 1, 2000, Pages 75-79

  Korb, Leroy ^a  

^a NORTHWEST HOSPITAL   (United States)

Author keywords

Bone neoplasms radiotherapy; Bone neoplasms secondary; Disease free survival; Fractures; Hemibody irradiation; Neoplasm metastasis; Pain; Palliative care; Phosphorus radioisotopes; Prostatic neoplasms; Quality of life; Radioisotopes therapeutic use; Radiotherapy dosage; Rhenium; Samarium; Spinal cord compression; Spinal cord neoplasms; Strontium radioisotopes; Survival rate; Ureteral obstruction

Indexed keywords

DEXAMETHASONE; PHOSPHORUS 32; RADIOPHARMACEUTICAL AGENT; RHENIUM 186; SAMARIUM 153; STRONTIUM 89; YTTRIUM 90;

BONE METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SPINAL CORD METASTASIS; TREATMENT INDICATION;

ANDROGEN ANTAGONISTS; BRACHYTHERAPY; DOSE FRACTIONATION; HEMIBODY IRRADIATION; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOISOTOPES;

EID: 0033986307     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(200001/02)18:1<75::AID-SSU9>3.0.CO;2-T     Document Type: Review

References (31)

1. Farkas A, Schneider D, Perrotti M, et al: National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening. Urology 1998;52: 444-448.
2. Yamashita K, Denno K, Ueda T, et al: Prognostic significance of bone metastases in patients with metastatic prostate cancer. Cancer 1993;71:1297-1302.
3. Altwein J, Ekman P, Barry M, et al: How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology 1997;49(4A Suppl):66-76.
4. Adami S: Bisphosphonates in prostate carcinoma [Review]. Cancer 1997;80(8 Suppl):1674-1679.
5. Bagshaw MA, Kaplan ID, Valdagni R, Cox RS: Radiation treatment of prostate bone metastases and the biological considerations [Review]. Adv Exp Med Biol 1992;324:255-268.
6. Ben-Josef E, Shamsa F, Williams AO, Porter AT: Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 1998;40:915-921.
7. Cheung A, Driedger AA: Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate. Radiology 1980;134:209-212.
8. Kim SI, Chen DC, Muggia FM: A new look at radionuclides therapy in metastatic disease of bone (review and prospects) [Review]. Anticancer Res 1988;8:681-684.
9. Collins C, Eary JF, Donaldson G, et al: Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J Nucl Med 1993;34:1839-1844.
10. Limouris G, Shukla SK, Manetou A, et al: Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer. Anticancer Res 1997;17(38):1699-1704.
11. Serafini AN: Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease [Review]. Int J Radiat Oncol Biol Phys 1994;30:1187-1194.
12. Tong D, Gillick L, Hendrickson FR: The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 1982;50:893-899.
13. Arcangeli G, Micheli A, Arcangeli G, et al: The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol 1989;14:95-101.
14. Mithal NP, Needham PR, Hoskin PJ: Retreatment with radiotherapy for painful bone metastases. Int J Radiat Oncol Biol Phys 1994; 29:1011-1014.
15. Chua ET, Chua EJ, Sethi VK: Half body irradiation for palliation of widespread metastatic bone disease. Ann Acad Med Singapore 1994;23:204-208.
16. Takahashi I, Niibe H, Mitsuhashi N, et al: Palliative radiotherapy of bone metastasis. Adv Exp Med Biol 1992;324:277-282.
17. Nielsen OS: Palliative treatment of bone metastases [Review]. Acta Oncol 1996;35 Suppl 5:58-60.
18. Epstein LM, Stewart BH, Antunez AR, et al: Half and total body radiation for carcinoma of the prostate. J Urol 1979;122:330-332.
19. Salazar OM, Rubin P, Hendrickson FR, et al: Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 1986;58:29-36.
20. Zelefsky MJ, Scher HI, Forman JD, et al: Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens. Int J Radiat Oncol Biol Phys 1989;17:1281-1285.
21. Salazar OM, DaMotta NW, Bridgman SM, et al: Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. Int J Radiat Oncol Biol Phys 1996;36:49-60.
22. Crawford ED, Kozlowski JM, Debruyne FM, et al: The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer [Review]. Urology 1994;44: 481-485.
23. Bos SD: An overview of current clinical experience with strontium-89 (Metastron). Prostate Suppl 1994;5:23-26.
24. Brundage MD, Crook JM, Lukka H: Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group. Cancer Prev Control 1998;2:79-87.
25. Bach F, Larsen BH, Rohde K, et al: Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir 1990;107:37-43.
26. Gilbert RW, Kim JH, Posner JB: Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978;3:40-51.
27. Zelefsky MJ, Scher HI, Krol G, et al: Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy. Cancer 1992;70:2319-2325.
28. Maranzano E, Latini P: Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys 1995;32:959-967.
29. Ahmann FR: Dilemmas in managing prostate carcinoma (Part II): metastatic disease. Geriatrics 1985;40:61-63, 67-70, 72.
30. Ampil FL: Radiation therapy palliation in malignancy-associated ureteral obstruction. Radiat Med 1989;7:282-286.
31. Perez CA, Cosmatos D, Garcia DM, et al: Irradiation in relapsing carcinoma of the prostate. Cancer 1993:71(3 Suppl):1110-1122.